Literature DB >> 32269469

Prazosin Outcomes in Older Veterans With Posttraumatic Stress Disorder.

Chelsea Khaw1, Tami Argo1.   

Abstract

Even at relatively high dosages, prazosin was well tolerated and significantly improved posttraumatic stress disorder severity and related nightmares in an older patient population.
Copyright © 2020 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Entities:  

Year:  2020        PMID： 32269469      PMCID： PMC7138342     

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


  14 in total

1.  Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.

Authors:  M A Raskind; E R Peskind; C Holmes; D S Goldstein
Journal:  Biol Psychiatry       Date:  1999-09-15       Impact factor: 13.382

Review 2.  Sleep disturbance as the hallmark of posttraumatic stress disorder.

Authors:  R J Ross; W A Ball; K A Sullivan; S N Caroff
Journal:  Am J Psychiatry       Date:  1989-06       Impact factor: 18.112

3.  Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans.

Authors:  Anne Germain; Robin Richardson; Douglas E Moul; Oommen Mammen; Gretchen Haas; Steven D Forman; Noelle Rode; Amy Begley; Eric A Nofzinger
Journal:  J Psychosom Res       Date:  2011-12-20       Impact factor: 3.006

4.  A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.

Authors:  Murray A Raskind; Elaine R Peskind; David J Hoff; Kimberly L Hart; Hollie A Holmes; Daniel Warren; Jane Shofer; James O'Connell; Fletcher Taylor; Christopher Gross; Kirsten Rohde; Miles E McFall
Journal:  Biol Psychiatry       Date:  2006-10-25       Impact factor: 13.382

5.  CSF norepinephrine concentrations in posttraumatic stress disorder.

Authors:  T D Geracioti; D G Baker; N N Ekhator; S A West; K K Hill; A B Bruce; D Schmidt; B Rounds-Kugler; R Yehuda; P E Keck; J W Kasckow
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

Review 6.  Prazosin for treatment of nightmares related to posttraumatic stress disorder.

Authors:  Heather R Taylor; Maisha Kelly Freeman; Marshall E Cates
Journal:  Am J Health Syst Pharm       Date:  2008-04-15       Impact factor: 2.637

7.  Abnormal noradrenergic function in posttraumatic stress disorder.

Authors:  S M Southwick; J H Krystal; C A Morgan; D Johnson; L M Nagy; A Nicolaou; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1993-04

8.  Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder.

Authors:  Elaine R Peskind; Lauren T Bonner; David J Hoff; Murray A Raskind
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-09       Impact factor: 2.680

9.  Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.

Authors:  Murray A Raskind; Elaine R Peskind; Evan D Kanter; Eric C Petrie; Allen Radant; Charles E Thompson; Dorcas J Dobie; David Hoff; Rebekah J Rein; Kristy Straits-Tröster; Ronald G Thomas; Miles M McFall
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

10.  A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.

Authors:  Murray A Raskind; Kris Peterson; Tammy Williams; David J Hoff; Kimberly Hart; Hollie Holmes; Dallas Homas; Jeffrey Hill; Colin Daniels; Jess Calohan; Steven P Millard; Kirsten Rohde; James O'Connell; Denise Pritzl; Kevin Feiszli; Eric C Petrie; Christopher Gross; Cynthia L Mayer; Michael C Freed; Charles Engel; Elaine R Peskind
Journal:  Am J Psychiatry       Date:  2013-09       Impact factor: 18.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.